Amalgamated Bank increased its holdings in shares of CVS Health (NYSE:CVS) by 9.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 128,289 shares of the pharmacy operator’s stock after acquiring an additional 11,356 shares during the quarter. Amalgamated Bank’s holdings in CVS Health were worth $9,301,000 as of its most recent SEC filing.
Other institutional investors have also modified their holdings of the company. Wealthcare Advisory Partners LLC lifted its holdings in CVS Health by 330.3% during the third quarter. Wealthcare Advisory Partners LLC now owns 1,291 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 991 shares during the period. Fieldpoint Private Securities LLC lifted its holdings in CVS Health by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock worth $105,000 after acquiring an additional 1,000 shares during the period. Cerebellum GP LLC bought a new stake in CVS Health during the fourth quarter worth $130,000. Capital Analysts LLC lifted its holdings in CVS Health by 240.1% during the fourth quarter. Capital Analysts LLC now owns 3,177 shares of the pharmacy operator’s stock worth $137,000 after acquiring an additional 2,243 shares during the period. Finally, Valeo Financial Advisors LLC bought a new stake in CVS Health during the third quarter worth $159,000. Institutional investors and hedge funds own 83.97% of the company’s stock.
A number of analysts recently commented on CVS shares. Mizuho set a $95.00 price target on CVS Health and gave the stock a “buy” rating in a report on Wednesday, January 24th. SunTrust Banks lifted their price target on CVS Health to $90.00 and gave the stock a “buy” rating in a report on Friday, January 5th. Needham & Company LLC lifted their price target on CVS Health from $85.00 to $88.00 and gave the stock a “buy” rating in a report on Tuesday, January 2nd. Tigress Financial reiterated a “buy” rating on shares of CVS Health in a report on Tuesday, December 26th. Finally, Royal Bank of Canada set a $89.00 target price on CVS Health and gave the company a “buy” rating in a research note on Thursday, February 8th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $86.65.
In other news, EVP Helena Foulkes sold 19,965 shares of CVS Health stock in a transaction on Friday, February 16th. The stock was sold at an average price of $71.04, for a total value of $1,418,313.60. Following the completion of the transaction, the executive vice president now directly owns 65,072 shares in the company, valued at $4,622,714.88. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 0.61% of the stock is currently owned by insiders.
Shares of NYSE CVS opened at $65.12 on Friday. The firm has a market capitalization of $67,577.98, a PE ratio of 11.04, a P/E/G ratio of 1.13 and a beta of 1.05. CVS Health has a fifty-two week low of $60.14 and a fifty-two week high of $84.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52.
CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion during the quarter, compared to analysts’ expectations of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the business earned $1.71 earnings per share. equities research analysts predict that CVS Health will post 6.32 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 3rd. Stockholders of record on Monday, April 23rd will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 3.07%. The ex-dividend date is Friday, April 20th. CVS Health’s dividend payout ratio (DPR) is presently 33.90%.
ILLEGAL ACTIVITY NOTICE: This story was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and reposted in violation of United States & international trademark and copyright legislation. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/04/21/cvs-health-cvs-position-increased-by-amalgamated-bank.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.